Home >
Medicine Info >
Malither 80 mg Injection
Loading interface...

Malither 80 mg Injection

Manufactured byThemis Medicare Ltd.
ContainsArtemether
Description
Malither 80 mg Injection is an effective anti-malarial medicine. It is used to treat severe malaria caused by Plasmodium falciparum and Plasmodium vivax strains when other medicines are not effective.
QUICK LINKS:
Side effectsConcernsUsage

Substitutes

List of substitutes for Malither 80 mg Injection

Larither 80 mg Injection
Ipca Laboratories Pvt. Ltd.

Side effects

Major & minor side effects for Malither 80 mg Injection

  • Nausea and Vomiting
  • Stomach discomfort and pain
  • Dizziness
  • Ringing or buzzing in the ears
  • Reduction in blood cell count
  • Increased heartbeat
  • Elevated liver enzymes

Uses of Malither 80 mg Injection

What is it prescribed for?

  • Acute uncomplicated malaria
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to artemether or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Severe complicated malarial infection

This medicine is not recommended for use if the patient is suffering from a severe and complicated malarial infection.

Liver/kidney impairment

This medicine should be used with caution in patients with liver/kidney diseases due to the increased risk of severe adverse effects. Close monitoring of liver/kidney function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Heart disease

This medicine should be used with caution in patients suffering from a pre-existing condition of the heart. Close monitoring of heart function and vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Drug resistance

This medicine is not recommended to stop before the prescribed duration though symptoms resolve or your condition is improved. Failure to do so might result in parasitic resistance to the drug and treatment of further infection with this medicine would become difficult.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Erythromycin

Quinidine

Chlorpromazine

Quetiapine

Terfenadine

Disease interactions

Liver Disease

This medicine should be administered with caution in patients having an impaired liver function. Appropriate diagnostic tests must be performed before determining the dose regimen. Suitable dose adjustment and frequent monitoring may be needed to ensure safe and effective use.

Kidney Disease

This medicine should be administered with caution in patients having an impaired kidney function. Appropriate diagnostic tests must be performed before determining the dose regimen. Suitable dose adjustment and frequent monitoring may be needed to ensure safe and effective use.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Effect on sleep is not established

How it works
This medicine works by interfering with certain vital functions in the cell of the malarial parasite present in the blood.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antimalarial agents

Schedule

Schedule H

Artemether | C16H26O5 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 8 June 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/68911#section=Top

WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Malaria: Artemether [Internet]. Apps.who.int. 2017 [cited 8 June 2017]. Available from:

http://apps.who.int/medicinedocs/en/d/Jh2922e/2.5.10.html

Artemether - DrugBank [Internet]. Drugbank.ca. 2020 [cited 6 February 2020]. Available from:

https://www.drugbank.ca/drugs/DB06697
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 3 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.